Table Of Content10/01/2019 LD-2 Disclosure Form
Clerk of the House of Representatives Secretary of the Senate
Legislative Resource Center Office of Public Records
B-106 Cannon Building 232 Hart Building
Washington, DC 20515 Washington, DC 20510
LOBBYING REPORT
http://lobbyingdisclosure.house.gov http://www.senate.gov/lobby
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
1. Registrant Name Organization/Lobbying Firm Self Employed Individual
Bayer Corporation (consolidated report)
2. Address
Address1 801 Pennsylvania Ave., NW Suite 745 Address2
City WASHINGTON State DC Zip Code 20004 Country USA
3. Principal place of business (if different than line 2)
City State Zip Code Country
4a. Contact Name b. Telephone Number c. E-mail
5. Senate ID#
Mr. Brian McCullough 2027378900 [email protected] 5632-12
7. Client Name Self Check if client is a state or local government or instrumentality
6. House ID#
Bayer Corporation (consolidated report) 312570000
TYPE OF REPORT
8. Year 2017 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report Termination Date 11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000 Less than $5,000
$5,000 or more $ $5,000 or more $ 2,120,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all
lobbying related income from the client (including all payments to the 14. REPORTING Check box to indicate expense accounting method.
registrant by any other entity for lobbying activities on behalf of the See instructions for description of options.
client).
Method A. Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the
Internal Revenue Code
Method C. Reporting amounts under section 162(e) of the Internal
Revenue Code
7/20/2017
Signature Digitally Signed By: Brian McCullough Date
3:39:54 PM
https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=6043A581-9D2B-49D1-ABD0-FEA9498B23F3&filingTypeID=60 1/12
10/01/2019 LD-2 Disclosure Form
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf
of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
Monitor legislative and administrative action related to pollinator health and habitat promotion.
Monitor legislative and administrative action related to pesticide registration.
Monitor legislative and administrative action related to biotechnology deregulation.
Monitor legislative and administrative action related to genetically modified labeling.
Monitor legislative and administrative action related to the Endangered Species Act and related reforms.
Monitor legislative and administrative action related to reauthorization of the farm bill.
Various issues related to proposed corporate acquisition.
S. 322, Pet and Women Safety Act of 2017.
S. 629, Preventing Antibiotic Resistance Act of 2017.
H.R. 909, Pet and Women Safety Act of 2017.
H.R. 953, Reducing Regulatory Burdens Act of 2017.
H.R. 1029, Pesticide Registration Enhancement Act of 2017.
H.R. 3040, Saving Americas Pollinators Act of 2017.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Agriculture - Dept of (USDA), Environmental Protection Agency
(EPA), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
First Name Last Name Suffix Covered Official Position (if applicable) New
Christopher Leahy
James McVaney
Ursula Wojciechowski
Edward Barron
Brian Nagle
Lindsay Morris
2015-2017, Dpty Staff Dir., Senate Comm. on Small
Business and Entrepreneurship; 2006-2012, Leg.
Lucas Tomanelli Asst./Subcom. Staff Dir./ Leg. Corr./Leg. Aide, Sen. Mike
Crapo; 2005-2006, Staff Asst., House Comm. on Ways and
Means, Subcom. on Oversight
2013-2017, Leg. Dir./Sr. Leg. Asst., Rep. Billy Long; 2011-
Peter Stehouwer 2012, Sen. Leg. Asst., Rep. Bill Huizenga; 2006-2010, Leg.
Asst./Leg. Corr./Staff Asst., Rep. Pete Hoekstra
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=6043A581-9D2B-49D1-ABD0-FEA9498B23F3&filingTypeID=60 2/12
10/01/2019 LD-2 Disclosure Form
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf
of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Monitor legislative and administrative action on appropriations and budget.
Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations.
S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth
the appropriate budgetary levels for fiscal years 2018 through 2026.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name Last Name Suffix Covered Official Position (if applicable) New
Christopher Leahy
Brian Nagle
James McVaney
Edward Barron
Ursula Wojciechowski
Julie Corcoran
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=6043A581-9D2B-49D1-ABD0-FEA9498B23F3&filingTypeID=60 3/12
10/01/2019 LD-2 Disclosure Form
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf
of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Monitor legislative and administrative action related to intellectual property protection.
17. House(s) of Congress and Federal agencies Check if None
U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
First Name Last Name Suffix Covered Official Position (if applicable) New
Christopher Leahy
Brian Nagle
Brian McCullough
Julie Corcoran
Edward Barron
Ursula Wojciechowski
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=6043A581-9D2B-49D1-ABD0-FEA9498B23F3&filingTypeID=60 4/12
10/01/2019 LD-2 Disclosure Form
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf
of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Monitor legislative and administrative action related to health care policy.
Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising.
Monitor legislative and administrative action related to the 340B Drug Pricing Program.
Monitor legislative and administrative action related to access to medical supplies.
Monitor legislative and administration action related to womens health issues.
Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program.
Monitor legislative and administrative action related to over-the-counter consumer care products.
Monitor legislative and administrative action related to dietary supplements.
Monitor legislative and administrative action related to servicing of medical device equipment.
Monitor legislative and administrative action related to companion labeling.
Monitor legislative and administrative action related to FDA monograph reform and user fees.
Monitor legislative and administrative action related to the repeal of the Affordable Care Act.
Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications.
S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting
export certifications.
S. 469, Affordable and Safe Prescription Drug Importation Act.
H.R. 749, Lower Drug Costs through Competition Act.
H.R. 1628, American Health Care Act of 2017.
H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices
intended for use with contrast agents.
H.R. 2118, Medical Device Servicing Safety and Accountability Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name Last Name Suffix Covered Official Position (if applicable) New
Christopher Leahy
Julie Corcoran
Brian Nagle
Lindsay Morris
2013-2017, Leg. Dir./Sr. Leg. Asst., Rep. Billy Long; 2011-
Peter Stehouwer 2012, Sen. Leg. Asst., Rep. Bill Huizenga; 2006-2010, Leg.
Asst./Leg. Corr./Staff Asst., Rep. Pete Hoekstra
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=6043A581-9D2B-49D1-ABD0-FEA9498B23F3&filingTypeID=60 5/12
10/01/2019 LD-2 Disclosure Form
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf
of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Monitor legislative and administrative action related to Medicare policy.
Monitor legislative and administrative action related to Medicaid policy.
H.R. 849, Protecting Seniors Access to Medicare Act of 2017.
S. 251, Protecting Medicare for Executive Action Act of 2017.
S. 260, Protecting Seniors Access to Medicare Act of 2017.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name Last Name Suffix Covered Official Position (if applicable) New
Christopher Leahy
Julie Corcoran
Brian Nagle
Lindsay Morris
2013-2017, Leg. Dir./Sr. Leg. Asst., Rep. Billy Long; 2011-
Peter Stehouwer 2012, Sen. Leg. Asst., Rep. Bill Huizenga; 2006-2010, Leg.
Asst./Leg. Corr./Staff Asst., Rep. Pete Hoekstra
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=6043A581-9D2B-49D1-ABD0-FEA9498B23F3&filingTypeID=60 6/12
10/01/2019 LD-2 Disclosure Form
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf
of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAR
16. Specific lobbying issues
Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name Last Name Suffix Covered Official Position (if applicable) New
Christopher Leahy
Brian McCullough
Ursula Wojciechowski
Edward Barron
James McVaney
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=6043A581-9D2B-49D1-ABD0-FEA9498B23F3&filingTypeID=60 7/12
10/01/2019 LD-2 Disclosure Form
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf
of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Monitor legislative and federal activity related to tax reform.
Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code.
S. 85, Restoring Access to Medication Act of 2017.
S. 108, Medical Device Access and Innovation Protection Act.
H.R. 184, Protect Medical Innovation Act of 2017.
H.R. 394, Restoring Access to Medication Act of 2017.
H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name Last Name Suffix Covered Official Position (if applicable) New
Christopher Leahy
Brian McCullough
Ursula Wojciechowski
Lindsay Morris
2013-2017, Leg. Dir./Sr. Leg. Asst., Rep. Billy Long; 2011-
Peter Stehouwer 2012, Sen. Leg. Asst., Rep. Bill Huizenga; 2006-2010, Leg.
Asst./Leg. Corr./Staff Asst., Rep. Pete Hoekstra
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=6043A581-9D2B-49D1-ABD0-FEA9498B23F3&filingTypeID=60 8/12
10/01/2019 LD-2 Disclosure Form
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf
of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Monitor legislative issues and administrative action related to trade.
Monitor legislative and administrative action related to Trans-Pacific Partnerships.
Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership.
Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides.
Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR), Environmental Protection Agency (EPA), Agriculture -
Dept of (USDA), Natl Security Council (NSC), Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name Last Name Suffix Covered Official Position (if applicable) New
Christopher Leahy
Brian McCullough
Ursula Wojciechowski
James McVaney
Julie Corcoran
Lindsay Morris
2015-2017, Dpty Staff Dir., Senate Comm. on Small
Business and Entrepreneurship; 2006-2012, Leg.
Lucas Tomanelli Asst./Subcom. Staff Dir./ Leg. Corr./Leg. Aide, Sen. Mike
Crapo; 2005-2006, Staff Asst., House Comm. on Ways and
Means, Subcom. on Oversight
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=6043A581-9D2B-49D1-ABD0-FEA9498B23F3&filingTypeID=60 9/12
10/01/2019 LD-2 Disclosure Form
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf
of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017.
H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017.
H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act.
H.R. 1431, EPA Science Advisory Board Reform Act of 2017.
S. 951, Regulatory Accountability Act of 2017.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name Last Name Suffix Covered Official Position (if applicable) New
Edward Barron
Chris Leahy
James McVaney
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=6043A581-9D2B-49D1-ABD0-FEA9498B23F3&filingTypeID=60 10/12
